New hope for advanced cancers: first human trial of YL211 begins

NCT ID NCT06384352

First seen Jan 05, 2026 · Last updated May 15, 2026 · Updated 14 times

Summary

This early-phase study tests a new drug, YL211, in about 155 adults with advanced solid tumors that have not responded to standard treatments. The study has three parts to find the safest dose and check for side effects, while also looking at whether the drug can shrink tumors. Participants receive YL211 by IV and are monitored closely.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • China-Japan Friendship Hospital

    RECRUITING

    Beijing, Beijing Municipality, 100029, China

    Contact

  • Comprehensive Cancer Centers of Nevada (CCCN) - Central Valley

    ACTIVE_NOT_RECRUITING

    Las Vegas, Nevada, 89169, United States

  • Florida Cancer Specialists & Research Institute (FCS) - Sarasota Cattlemen Office

    RECRUITING

    Sarasota, Florida, 34232-6422, United States

    Contact Email: •••••@•••••

    Contact

  • Gosford Hospital

    ACTIVE_NOT_RECRUITING

    Gosford, New South Wales, 2250, Australia

  • Monash Health

    RECRUITING

    Melbourne, Australia

    Contact Email: •••••@•••••

    Contact

  • NEXT Oncology - Dallas

    RECRUITING

    Irving, Texas, 75039, United States

    Contact Email: •••••@•••••

    Contact

  • NEXT Oncology - Houston

    RECRUITING

    Houston, Texas, 77055, United States

    Contact

  • NEXT San Antonio

    RECRUITING

    San Antonio, Texas, 78229, United States

    Contact Email: •••••@•••••

  • One Clinical Research - Nedlands

    NOT_YET_RECRUITING

    Nedlands, Western Australia, 6009, Australia

    Contact

  • Princess Margaret Hospital

    RECRUITING

    Toronto, Toronto, Canada

    Contact Email: •••••@•••••

    Contact

  • Sarah Cannon Research Institute (SCRI) at HealthONE

    RECRUITING

    Denver, Colorado, 80218-1238, United States

    Contact Email: •••••@•••••

    Contact

  • Sarah Cannon Research Institute at Florida Cancer Specialists

    RECRUITING

    Orlando, Florida, 32827, United States

    Contact

    Contact Email: •••••@•••••

  • Sun Yat-sen University Cancer Center

    RECRUITING

    Guangzhou, China

    Contact Email: •••••@•••••

    Contact

    Contact

  • The First Affiliated Hospital - Zhejiang University School of Medicine

    RECRUITING

    Hangzhou, Zhejiang, 310003, China

    Contact

  • The Ottawa Hospital - General Campus

    NOT_YET_RECRUITING

    Ottawa, Canada

    Contact Email: •••••@•••••

    Contact

  • The University of Texas - MD Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

    Contact Email: •••••@•••••

  • University of Cincinnati Vontz Center for Molecular Studies

    RECRUITING

    Cincinnati, Ohio, 45219, United States

    Contact

  • University of Colorado Hospital - Anschutz Cancer Pavilion

    NOT_YET_RECRUITING

    Aurora, Colorado, 80045, United States

    Contact

    Contact Email: •••••@•••••

  • Wenzhou Medical University - The First Affiliated Hospital

    RECRUITING

    Wenzhou, Zhejiang, 325000, China

    Contact

  • West China Hospital, Sichuan University

    NOT_YET_RECRUITING

    Chengdu, China

    Contact Email: •••••@•••••

    Contact

  • Yale School of Medicine - Yale Cancer Center - Smilow Cancer Hospital Care Centers - North Haven

    RECRUITING

    North Haven, Connecticut, 06473-2142, United States

    Contact Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.